mTOR in tuberous sclerosis and other neurological disorders [2]

Epilepsia

Volumn 48, Issue 8, 2007, Pages 1630-1631

  Franz, David Neal ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; GLUTAMATE RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RAPAMYCIN; S6 KINASE; TARGET OF RAPAMYCIN KINASE; VOLTAGE GATED POTASSIUM CHANNEL;

BRAIN FUNCTION; CELL CYCLE PROGRESSION; CELL GROWTH; CLINICAL TRIAL; DENDRITIC SPINE; DISEASE ASSOCIATION; DISEASE CONTROL; GENE MUTATION; HUMAN; LETTER; NERVE CELL DIFFERENTIATION; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SEIZURE; TUBEROUS SCLEROSIS;

EPILEPSY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; NERVOUS SYSTEM DISEASES; PROTEIN KINASES; SIROLIMUS; TREATMENT OUTCOME; TUBEROUS SCLEROSIS;

EID: 34547849527     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2007.01178_2.x     Document Type: Letter

References (17)

1. Chen S, Atkins CM, Liu CL, Alonso OF, Dietrich WD, Hu BR 2007) Alterations in mammalian target of rapamycin signaling pathways after traumatic brain injury. J Cereb Blood Flow Metab 27 : 939 949.
2. D'Arcangelo G, Ljungberg MC, et al 2007) Targeting common signal pathways in cortical dysplasia. Presentation at NINDS "Curing Epilepsy 2007" Conference, Bethesda, MD, March 29, 2007.
3. Franz DN 2007) Rapamycin therapy of neurologic disease in Tuberous Sclerosis Complex. Presentation at NINDS "Curing Epilepsy 2007" Conference, Bethesda, MD, March 29, 2007.
4. Gong R, Park CS, Abassi NR 2006) Roles of glutamate receptors and the mTOR signaling pathway in activity-dependent protein synthesis in hippocampal neurons. J Biol Chem 281 : 18802 18815.
5. Holmes G, Stafstrom C 2007) Tuberous sclerosis complex and epilepsy: recent developments and future challenges. Epilepsia 48 : 617 630.
6. Inoki K, Guan KL 2006) Complexity of the TOR signaling network. Trends Cell Biol 16 : 206 212.
7. Jaworski J, Sheng M 2006) The growing role of mTOR in neuronal development and plasticity. Mol Neurobiol 34 : 205 219.
8. Jaworski J, Spangler S, Seeburg DP, Hoogenraad CC, Sheng M 2005) Control of dendritic arborization by the phosphoinositide-3′-kinase-Akt-mammalian target of rapamycin pathway. J Neurosci 25 : 11300 11312.
9. Kwon CH, Luikart BW, Powell CM, Zhou J, Matheny SA, Zhang W, Li Y, Baker SJ, Parada LF 2006) Pten regulates neuronal arborization and social interaction in mice. Neuron 50 : 377 388.
10. Lenz G, Avruch J 2005) Glutmatergic regulation of the S6kinase in primary mouse neurons. J Biol Chem 280 : 38121 38124.
11. Ljungberg MC, Bhattacharjee MB, Lu Y, Armstrong DL, Yoshor D, Swann JW, Sheldon M, D'Arcangelo G 2006) Activation of mammalian target of rapamycin in cytomegalic neurons of human cortical dysplasia. Ann Neurol 60 : 420 429.
12. Ma L, Teruya-Feldstein J, Bonner P, et al 2007) Identification of S664 TSC2 phosphorylation as a marker for Erk-mediated mTOR activation in tuberous sclerosis and human cancer. Cancer Res (in press).
13. Meikle LM, Talos DM, Onda H, Walker V, Zhang H, Jensen FE, Kwiatkowski DJ 2005) Characterization of a murine neuronal specific knockout of TSC1. Epilepsia 46 (Suppl. 8 273.
14. Peng T, Golub T, Sabatini D 2002) The immunosuppressant Rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation. Mol Cell Biol 22 : 5575 5584.
15. Raab-Graham KF, Heddick PC, Jan YN, Jan LY 2006) Activity and mTOR dependent suppression of Kv1.1 channel mRNA translation in dendrites. Science 314 : 144 148.
16. Tavazoie SF, Alvarez VA, Ridenour DA, Kwiatkowski DJ, Sabatini BL 2005) Regulation of neuronal morphology and function by the tumor suppressor genes Tsc1 and Tsc2. Nat Neurosci 8 : 1727 1734.
17. Yang Q, Inoki K, Kim E, Guan KL 2006) TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity. Proc Natl Acad Sci USA 103 : 6811 6816.